Back
78
39
20
58
45
Also listed as
MRPZF
OTC
Day Range
$9.16
$9.25
52-Week Range
$9.16
$13.69
Volume
150
50D / 200D Avg
$10.52
/
$11.72
Prev Close
$9.42
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (609 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.7 | 11.1 |
| P/B | 0.2 | 1.4 |
| ROE % | 26.2 | 10.7 |
| Net Margin % | 9.1 | 5.1 |
| Rev Growth 5Y % | 133.8 | 8.2 |
| D/E | 0.7 | 0.8 |
Key Takeaways
Revenue grew 133.79% annually over 5 years — strong growth
ROE of 26.24% indicates high profitability
Generating 7.60B in free cash flow
P/E of 0.65 — trading at a low valuation
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 126.71%
Growth
Revenue Growth (5Y)
133.79%
Revenue (1Y)7.08%
Earnings (1Y)11.19%
FCF Growth (3Y)403.31%
Quality
Return on Equity
26.24%
ROIC18.01%
Net Margin9.06%
Op. Margin13.20%
Safety
Debt / Equity
0.65
Current Ratio1.54
Interest Coverage6.45
Valuation
P/E Ratio
0.65
P/B Ratio0.18
EV/EBITDA1.30
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.08% | Revenue Growth (3Y) | 363.45% |
| Earnings Growth (1Y) | 11.19% | Earnings Growth (3Y) | 346.27% |
| Revenue Growth (5Y) | 133.79% | Earnings Growth (5Y) | 117.88% |
| Profitability | |||
| Revenue (TTM) | 40.25B | Net Income (TTM) | 3.65B |
| ROE | 26.24% | ROA | 11.21% |
| Gross Margin | 41.43% | Operating Margin | 13.20% |
| Net Margin | 9.06% | Free Cash Flow (TTM) | 7.60B |
| ROIC | 18.01% | FCF Growth (3Y) | 403.31% |
| Safety | |||
| Debt / Equity | 0.65 | Current Ratio | 1.54 |
| Interest Coverage | 6.45 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 0.65 | P/B Ratio | 0.18 |
| P/S Ratio | 0.06 | PEG Ratio | 0.00 |
| EV/EBITDA | 1.30 | Dividend Yield | 0.04% |
| Market Cap | 2.36B | Enterprise Value | 6.90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 40.25B | 37.59B | 1.87B | 1.82B | 1.35B |
| Net Income | 3.65B | 3.28B | 183.12M | 225.35M | 161.83M |
| EPS (Diluted) | 1371.80 | 12.43 | 0.70 | 0.86 | 0.61 |
| Gross Profit | 16.67B | 15.44B | 748.42M | 755.09M | 580.94M |
| Operating Income | 5.31B | 5.11B | 236.03M | 294.09M | 198.31M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32.54B | 29.82B | 1.62B | 1.55B | 1.35B |
| Total Liabilities | 18.12B | 14.39B | 837.14M | 726.84M | 612.00M |
| Shareholders' Equity | 13.43B | 14.37B | 733.49M | 825.05M | 733.97M |
| Total Debt | 8.69B | 8.71B | 519.09M | 507.24M | 402.54M |
| Cash & Equivalents | 4.15B | 2.80B | 81.27M | 315.62M | 335.16M |
| Current Assets | 15.67B | 12.98B | 663.83M | 778.85M | 716.97M |
| Current Liabilities | 10.16B | 7.48B | 416.34M | 316.10M | 286.94M |
Strategy Scores
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#48 of 1024
#274 of 616
#418 of 658
Custom
Balanced Risk
#31 of 148
Custom
Lower Risk
#68 of 136
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Balanced Risk
Mar 24, 2026
Entered
Lower Risk
Mar 24, 2026